Sodium Glucose Cotransporter 2 Inhibition by Canagliflozin Attenuates Intrarenal Angiotensinogen Augmentation in Type 2 Diabetes Mellitus.

被引：0
|
作者：
Woods, T. Cooper [1 ]
Satou, Ryousule [1 ]
Miyata, Kayoko [1 ]
Katsurada, Akemi [1 ]
Dugas, Courtney M. [1 ]
Lightell, Daniel, Jr. [1 ]
Navar, L. Gabriel [1 ]
机构：
[1] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
来源：
HYPERTENSION | 2017年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
AP464
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
    Cherney, David
    Lund, Soren S.
    Perkins, Bruce A.
    Groop, Per-Henrik
    Cooper, Mark E.
    Kaspers, Stefan
    Pfarr, Egon
    Woerle, Hans J.
    von Eynatten, Maximilian
    DIABETOLOGIA, 2016, 59 (09) : 1860 - 1870
  • [42] The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
    David Cherney
    Søren S. Lund
    Bruce A. Perkins
    Per-Henrik Groop
    Mark E. Cooper
    Stefan Kaspers
    Egon Pfarr
    Hans J. Woerle
    Maximilian von Eynatten
    Diabetologia, 2016, 59 : 1860 - 1870
  • [43] Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes
    Yoshimoto, Takuo
    Furuki, Takayuki
    Kobori, Hiroyuki
    Miyakawa, Masaaki
    Imachi, Hitomi
    Murao, Koji
    Nishiyama, Akira
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (07) : 1057 - 1061
  • [44] Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro
    Yamamoto, Leona
    Yamashita, Shinichi
    Nomiyama, Takashi
    Kawanami, Takako
    Hamaguchi, Yuriko
    Shigeoka, Toru
    Horikawa, Tsuyoshi
    Tanaka, Yuki
    Yanase, Toshihiko
    Kawanami, Daiji
    Iwasaki, Akinori
    DIABETOLOGY INTERNATIONAL, 2021, 12 (04) : 389 - 398
  • [45] CARDIOVASCULAR DISEASE AND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITORS: A NEW ERA FOR TYPE 2 DIABETES MELLITUS Introduction
    Chilton, Robert J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (01): : S1 - S3
  • [46] Effects of Sodium Glucose Cotransporter-2 Inhibitors on Serum Uric Acid in Type 2 Diabetes Mellitus
    Ahmadieh, Hala
    Azar, Sami
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (09) : 507 - 512
  • [47] The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Type 2 Diabetes Mellitus
    Taylor, Shawn Riser
    Harris, Kira B.
    PHARMACOTHERAPY, 2013, 33 (09): : 984 - 999
  • [48] Association of sodium-glucose cotransporter 2 inhibitors with the incidence of corneal diseases in type 2 diabetes mellitus
    Tsai, Tsan-Yu
    Yang, Po-Jen
    Chao, Shih-Chun
    Lee, Chia-Yi
    Huang, Jing-Yang
    Yang, Shun-Fa
    Lin, Hung-Yu
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (03): : 583 - 592
  • [49] Effect of sodium glucose cotransporter 2 inhibitor on sympathetic nerve activity in type 2 diabetes mellitus patients
    Hamaoka, T.
    Murai, H.
    Sugimoto, H.
    Mukai, Y.
    Okabe, Y.
    Tokuhisa, H.
    Inoue, O.
    Takashima, S.
    Kato, T.
    Usui, S.
    Furusho, H.
    Takamura, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 742 - 742
  • [50] The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review
    Soodeh Jahangiri
    Mojtaba Malek
    Sanjay Kalra
    Mohammad E. Khamseh
    Diabetes Therapy, 2023, 14 : 2015 - 2030
12345